Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1992-11-24
1994-04-12
Kim, Kay K.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 88, 424 858, 530405, 530411, 435101, 435207, A61K 39385, A61K, A61K, C12P 1904, C07K 1702
Patent
active
053023862
ABSTRACT:
Antigens and vaccines containing purified oligomers (1-50 units) of the repeating pentasaccharide unit of type III Group B Stretococcus (III GBS) polysaccharide capsule. Methods of making the antigen by recovering polysaccharide from cultured III GBS or medium and digesting the polysaccharide with a specific endo-.beta.-galactosidase. Enzymatic cleavage of bacterial polysaccharide to make purified oligomers. A purified trypsin-resistant C surface protein, m.w. about 14,000 and vaccine. Passive immunization using the above vaccines. Immunoassays for GBS immunodeterminants or anti-GBS antibodies.
REFERENCES:
patent: 4207414 (1980-06-01), Kasper
patent: 4356263 (1982-10-01), Kasper
patent: 4413057 (1983-11-01), Carlo et al.
patent: 4591552 (1986-05-01), Neurath
Nakazawa, et al, J. Biol. Chem., 250(3):912-917 (1975).
Kitamikado, et al, J. Biol. Chem, 256(8):3906-3909 (1981).
Russell, et al., J. Immunol., 109(1):90-96 (1972).
Insel et al., J. Exp. Med.vol. 163, 1986, pp. 262-269.
Jennings et al., Canadian J. Biochem., vol. 58, 1980, pp. 112-120.
Jennings et al., Biochem., vol. 20, 1981, pp. 4511-4518.
Lancefield, J. Exp. Med., vol. 108, pp. 329-341 (1938).
Russell-Jones, J. Exper. Med., vol. 160, p. 1476 (1984).
Baker, "Group B Streptococcal Infections" in Advances in Internal Medicine, vol. 25, pp. 475-500 (1980).
Lancefield et al., J. Exp. Med., vol. 142, pp. 165-179 (1975).
Henrichsen et al., Int. J. of Systematic Bacteriol., vol. 34, p. 500 (1984).
Wilkinson et al., Infect. Immunol., vol. 4, pp. 596-604 (1971).
Bevanger et al., Acta Path. Microbiol. Scand. Sect. B, vol. 87, pp. 51-54 (1979).
Bevanger et al., Acta Path. Microbiol. Scand. Sect. B, vol. 89, pp. 205-209 (1981).
Insel and Andersen, J. Exp. Med., vol. 163, p. 262 (1986).
Jennings Harold J.
Kasper Dennis L.
Levy Nancy J.
Wessels Michael R.
Brigham and Women's Hospital, Inc.
Kim Kay K.
LandOfFree
Bacterial antigens, antibodies, vaccines and methods of manufact does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bacterial antigens, antibodies, vaccines and methods of manufact, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacterial antigens, antibodies, vaccines and methods of manufact will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2097086